Nanosilver as a new generation of nanoproduct in biomedical applications

Trends in Biotechnology

Volumn 28, Issue 11, 2010, Pages 580-588

  Chaloupka, Karla ^a,c   Malam, Yogeshkumar ^a   Seifalian, Alexander M ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTI-INFLAMMATORY EFFECTS; ANTIBACTERIAL COATINGS; BIOMEDICAL APPLICATIONS; MEDICAL DEVICES; MEDICAL FIELDS; NANO SILVER; NOSOCOMIAL INFECTION; SILVER NANOPARTICLES; SYNTHESIS METHOD; WOUND HEALING;

BIOMEDICAL ENGINEERING; MEDICAL APPLICATIONS;

SILVER;

BONE CEMENT; NANOSILVER; SILVER NANOPARTICLE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; DRUG COATING; HOSPITAL INFECTION; HUMAN; MICROORGANISM; NANOBIOTECHNOLOGY; NEUROSURGERY; NONHUMAN; PRIORITY JOURNAL; REVIEW; WOUND DRESSING;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; BIOTECHNOLOGY; HUMANS; NANOPARTICLES; SILVER; WOUND HEALING;

EID: 77957766556     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2010.07.006     Document Type: Review

References (79)

1. Benn T.M., Westerhoff P. Nanoparticle silver released into water from commercially available sock fabrics. Environ. Sci. Technol. 2008, 42:4133-4139.
2. Ling J., et al. Visual sandwich immunoassay system on the basis of plasmon resonance scattering signals of silver nanoparticles. Anal. Chem. 2009, 81:1707-1714.
3. Chaudhry Q., et al. Applications and implications of nanotechnologies for the food sector. Food Addit. Contam. A 2008, 25:241-258.
4. Nadworny P.L., et al. Anti-inflammatory activity of nanocrystalline silver in a porcine contact dermatitis model. Nanomedicine 2008, 4:241-251.
5. Sibbald R.G., et al. Bacteriology, inflammation, and healing: a study of nanocrystalline silver dressings in chronic venous leg ulcers. Adv. Skin Wound. Care 2007, 20:549-558.
6. Tian J., et al. Topical delivery of silver nanoparticles promotes wound healing. Chem. Med. Chem. 2007, 2:129-136.
7. Wright J.B., et al. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen. 2002, 10:141-151.
8. Huang Y., et al. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis. Burns 2007, 33:161-166.
9. Atiyeh B.S., et al. Effect of silver on burn wound infection control and healing: review of the literature. Burns 2007, 33:139-148.
10. Sladkova M., et al. Surface-enhanced Raman scattering from a single molecularly bridged silver nanoparticle aggregate. J. Mol. Struct. 2009, 924-926:567-570.
11. Choi O., et al. The inhibitory effects of silver nanoparticles, silver ions, and silver chloride colloids on microbial growth. Water Res. 2008, 42:3066-3074.
12. Foldbjerg R., et al. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol. Lett. 2009, 190:156-162.
13. Sun Y.G., et al. Transformation of silver nanospheres into nanobelts and triangular nanoplates through a thermal process. Nano Lett. 2003, 3:675-679.
14. Panacek A., et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J. Phys. Chem. B 2006, 110:16248-16253.
15. Sato-Berru R., et al. Silver nanoparticles synthesized by direct photoreduction of metal salts. Application in surface-enhanced Raman spectroscopy. J. Raman Spectrosc. 2009, 40:376-380.
16. Courrol L.C., et al. A simple method to synthesize silver nanoparticles by photo-reduction. Colloids Surf. A 2007, 305:54-57.
17. Sharma V.K., et al. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv. Colloid Interface Sci. 2009, 145:83-96.
18. Shahverdi A.R., et al. Rapid synthesis of silver nanoparticles using culture supernatants of Enterobacteria: a novel biological approach. Process Biochem. 2007, 42:919-923.
19. Shaligram N.S., et al. Biosynthesis of silver nanoparticles using aqueous extract from the compactin producing fungal strain. Process Biochem. 2009, 44:939-943.
20. Lochner N., et al. Silver nanoparticle enhanced immunoassays: one step real time kinetic assay for insulin in serum. Eur. J. Pharm. Biopharm. 2003, 56:469-477.
21. Sanpui P., et al. The antibacterial properties of a novel chitosan-Ag-nanoparticle composite. Int. J. Food Microbiol. 2008, 124:142-146.
22. Morones J.R., et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346-2353.
23. Shrivastava S. Characterization of enhanced antibacterial effects of novel silver nanoparticles. Nanotechnology 2007, 18:225103-225112.
24. Yang W.J., et al. Food storage material silver nanoparticles interfere with DNA replication fidelity and bind with DNA. Nanotechnology 2009, 20:085102.
25. Lok C.N., et al. Silver nanoparticles: partial oxidation and antibacterial activities. J. Biol. Inorg. Chem. 2007, 12:527-534.
26. Park H.J., et al. Silver-ion-mediated reactive oxygen species generation affecting bactericidal activity. Water Res. 2009, 43:1027-1032.
27. Carlson C., et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B 2008, 112:13608-13619.
28. Pal S., et al. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the gram-negative bacterium Escherichia coli. Appl. Environ. Microbiol. 2007, 73:1712-1720.
29. Silver S. Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol. Rev. 2003, 27:341-353.
30. Yamanaka M., et al. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Appl. Environ. Microbiol. 2005, 71:7589-7593.
31. Jung W.K., et al. Antibacterial activity and mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. Appl. Environ. Microbiol. 2008, 74:2171-2178.
32. Sondi I., Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 2004, 275:177-182.
33. Lok C.N., et al. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome Res. 2006, 5:916-924.
34. Califf R.M., et al. Novel approaches to clinical trials: device-related infections. Am. Heart J. 2004, 147:599-604.
35. Stevens K.N.J., et al. The relationship between the antimicrobial effect of catheter coatings containing silver nanoparticles and the coagulation of contacting blood. Biomaterials 2009, 30:3682-3690.
36. Grunkemeier G.L., et al. Prosthetic heart valves: objective performance criteria versus randomized clinical trial. Ann. Thorac. Surg. 2006, 82:776-780.
37. Jamieson W.R.E., et al. Seven-year results with the St Jude Medical Silzone mechanical prosthesis. J. Thorac. Cardiovasc. Surg. 2009, 137:1109-1115.
38. Andara M., et al. Hemocompatibility of diamondlike carbon-metal composite thin films. Diamond Relat. Mater. 2006, 15:1941-1948.
39. Ghanbari H., et al. Polymeric heart valves: new materials, emerging hopes. Trends Biotechnol. 2009, 27:359-367.
40. Samuel U., Guggenbichler J.P. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter. Int. J. Antimicrob. Agents 2004, 23:75-78.
41. Roe D., et al. Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J. Antimicrob. Chemother. 2008, 61:869-876.
42. Bayston R., et al. Prevention of infection in neurosurgery: role of " antimicrobial" catheters. J. Hosp. Infect. 2007, 65:39-42.
43. Orsi G.B., et al. Hospital-acquired infection surveillance in a neurosurgical intensive care unit. J. Hosp. Infect. 2006, 64:23-29.
44. Galiano K., et al. Silver segregation and bacterial growth of intraventricular catheters impregnated with silver nanoparticles in cerebrospinal fluid drainages. Neurol. Res. 2008, 30:285-287.
45. Lackner P., et al. Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit. Care 2008, 8:360-365.
46. Alt V., et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004, 25:4383-4391.
47. Jiranek W.A., et al. Antibiotic-loaded bone cement for infection prophylaxis in total joint replacement. J. Bone Jt. Surg. Am. 2006, 88:2487-2500.
48. Chen J., et al. [Effect of silver nanoparticle dressing on second degree burn wound]. Zhonghua Wai Ke. Za Zhi. 2006, 44:50-52.
49. Vlachou E., et al. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns 2007, 33:979-985.
50. Asz J., et al. Treatment of toxic epidermal necrolysis in a pediatric patient with a nanocrystalline silver dressing. J. Pediatr. Surg. 2006, 41:e9-e12.
51. ®). Burns 2007, 33:793-797.
52. Lu S., et al. Construction, application and biosafety of silver nanocrystalline chitosan wound dressing. Burns 2008, 34:623-628.
53. Gravante G., et al. Nanocrystalline silver: a systematic review of randomized trials conducted on burned patients and an evidence-based assessment of potential advantages over older silver formulations. Ann. Plast. Surg. 2009, 63:201-205.
54. Castillo P.M., et al. Tiopronin monolayer-protected silver nanoparticles modulate IL-6 secretion mediated by Toll-like receptor ligands. Nanomedicine 2008, 3:627-635.
55. Boucher W., et al. Intravesical nanocrystalline silver decreases experimental bladder inflammation. J. Urol. 2008, 179:1598-1602.
56. Chen X., Schluesener H.J. Nanosilver: a nanoproduct in medical application. Toxicol. Lett. 2008, 176:1-12.
57. Impellitteri C.A., et al. The speciation of silver nanoparticles in antimicrobial fabric before and after exposure to a hypochlorite/detergent solution. J. Environ. Qual. 2009, 38:1528-1530.
58. Reijnders L. Cleaner nanotechnology and hazard reduction of manufactured nanoparticles. J. Cleaner Prod. 2006, 14:124-133.
59. Hsin Y.H., et al. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol. Lett. 2008, 179:130-139.
60. Drake P.L., Hazelwood K.J. Exposure-related health effects of silver and silver compounds: a review. Ann. Occup. Hyg. 2005, 49:575-585.
61. Hussain S.M., et al. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 2005, 19:975-983.
62. Braydich-Stolle L., et al. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. 2005, 88:412-419.
63. Kim Y.S., et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal. Toxicol. 2008, 20:575-583.
64. Lee K.J., et al. In vivo imaging of transport and biocompatibility of single silver nanoparticles in early development of zebrafish embryos. ACS Nano 2007, 1:133-143.
65. Asharani P.V., et al. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 2009, 3:279-290.
66. Samberg M.E., et al. Evaluation of silver nanoparticle toxicity in skin in vivo and keratinocytes in vitro. Environ. Health Perspect. 2010, 118:407-413.
67. Ahuja R.B., et al. A prospective double-blinded comparative analysis of framycetin and silver sulphadiazine as topical agents for burns: a pilot study. Burns 2009, 35:672-676.
68. Jain J., et al. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol. Pharm. 2009, 6:1388-1401.
69. Kumar A., et al. Silver-nanoparticle-embedded antimicrobial paints based on vegetable oil. Nat. Mater. 2008, 7:236-241.
70. Vigneshwaran N., et al. A novel one-pot 'green' synthesis of stable silver nanoparticles using soluble starch. Carbohydr. Res. 2006, 341:2012-2018.
71. Chen P., et al. Synthesis of silver nanoparticles by γ-ray irradiation in acetic water solution containing chitosan. Radiat. Phys. Chem. 2007, 76:1165-1168.
72. Xu G.-N., et al. Preparation and characterization of stable monodisperse silver nanoparticles via photoreduction. Colloids Surf. A 2008, 320:222-226.
73. Tien D.C., et al. Colloidal silver fabrication using the spark discharge system and its antimicrobial effect on Staphylococcus aureus. Med. Eng. Phys. 2008, 30:948-952.
74. Kora A.J., et al. Superior bactericidal activity of SDS capped silver nanoparticles: synthesis and characterization. Mater. Sci. Eng. C 2009, 29:2104-2109.
75. Graf P., et al. Peptide-coated silver nanoparticles: synthesis, surface chemistry, and pH-triggered, reversible assembly into particle assemblies. Chemistry 2009, 15:5831-5844.
76. Asharani P.V., et al. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 2008, 19:255102.
77. Ruparelia J.P., et al. Strain specificity in antimicrobial activity of silver and copper nanoparticles. Acta Biomater. 2008, 4:707-716.
78. Elechiguerra J.L., et al. Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 2005, 3:6.
79. Lara H.H., et al. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnol. 2010, 8:1.